Infectious Disease Diagnostics Market to 2022 - Top Technologies on Hepatitis, Influenza and NGS
The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. Base year considered for study is 2016, and forecast for market size is provided for period betwe
(EMAILWIRE.COM, September 15, 2018 ) Key players in infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), biomérieux (France), Bio-Rad (US), and Roche (Switzerland). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, collaborations and as well as organic strategies such as expansions and product launches & approvals to sustain their growth in the market.
Download Sample Papers of Infectious Disease Diagnostics Market spread across 170 Pages, Profiling 12 Companies and Supported with 85 Tables and 35 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=258351 .
Growth in infectious disease diagnostics market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics
Infectious Disease Diagnostics Market, By Disease Type
1 Introduction
2 Hepatitis Diagnostics Market, By Technology
3 Human Immunodeficiency Virus (HIV)
4 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
5 Hospital-Acquired Infections (HAIS)
6 Human Papillomavirus (HPV)
7 Tuberculosis Diagnostics Market, By Technology
8 Influenza
9 Influenza Diagnostics Market, By Technology
Infectious Disease Diagnostics Market, By End User
1 Introduction
2 Hospital/Clinical Laboratories
3 Reference Laboratories
4 Physician Offices
5 Academic/Research Institutes
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=258351 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Competitive Landscape
1 Market Overview
2 Market Ranking Analysis, 2017
3 Competitive Situation and Trends
4 Product Launches and Approvals
5 Collaborations, Agreements, and Partnerships
6 Acquisitions
7 Expansions
Connect for More Details for Discount and More Information “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/discount?rname=258351 .
The infectious disease diagnostics market is segmented into major seven technologies, namely, immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, and other technologies. In 2017, the immunodiagnostics segment accounted for the largest share of the global market.
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market. Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.
Download Sample Papers of Infectious Disease Diagnostics Market spread across 170 Pages, Profiling 12 Companies and Supported with 85 Tables and 35 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=258351 .
Growth in infectious disease diagnostics market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics
Infectious Disease Diagnostics Market, By Disease Type
1 Introduction
2 Hepatitis Diagnostics Market, By Technology
3 Human Immunodeficiency Virus (HIV)
4 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
5 Hospital-Acquired Infections (HAIS)
6 Human Papillomavirus (HPV)
7 Tuberculosis Diagnostics Market, By Technology
8 Influenza
9 Influenza Diagnostics Market, By Technology
Infectious Disease Diagnostics Market, By End User
1 Introduction
2 Hospital/Clinical Laboratories
3 Reference Laboratories
4 Physician Offices
5 Academic/Research Institutes
Click Here for More Information on Infectious Disease Diagnostics Market with Forecast and Company Profiles at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=258351 .
Geographically, the Infectious disease diagnostics market Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Competitive Landscape
1 Market Overview
2 Market Ranking Analysis, 2017
3 Competitive Situation and Trends
4 Product Launches and Approvals
5 Collaborations, Agreements, and Partnerships
6 Acquisitions
7 Expansions
Connect for More Details for Discount and More Information “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/discount?rname=258351 .
The infectious disease diagnostics market is segmented into major seven technologies, namely, immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarrays, and other technologies. In 2017, the immunodiagnostics segment accounted for the largest share of the global market.
Global infectious disease diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, physician offices, academic/research institutes, and other end users. In 2017, the hospitals/clinical laboratories segment accounted for the largest share of the global market. Also, this segment is expected to grow at the highest CAGR during the forecast period due to the large number of diagnostic tests carried out in hospitals.
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results